Survival by dialysis modality in critically ill patients with acute kidney injury.

Among critically ill patients, acute kidney injury (AKI) requiring dialysis is associated with mortality rates generally in excess of 50%. Continuous renal replacement therapies (CRRT) often are recommended and widely used, although data to support its superiority over intermittent hemodialysis (IHD) are lacking. Data from the Program to Improve Care in Acute Renal Disease (PICARD), a multicenter observational study of AKI, were analyzed. Among 398 patients who required dialysis, the risk for death within 60 d was examined by assigned initial dialysis modality (CRRT [n = 206] versus IHD [n = 192]) using standard Kaplan-Meier product limit estimates, proportional hazards ("Cox") regression methods, and a propensity score approach to account for selection effects. Crude survival rates were lower for patients who were treated with CRRT than IHD (survival at 30 d 45 versus 58%; P = 0.006). Adjusted for age, hepatic failure, sepsis, thrombocytopenia, blood urea nitrogen, and serum creatinine and stratified by site, the relative risk for death associated with CRRT was 1.82 (95% confidence interval 1.26 to 2.62). Further adjustment for the propensity score did not materially alter the association (relative risk 1.92; 95% confidence interval 1.28 to 2.89). Among critically ill patients with AKI, CRRT was associated with increased mortality. Although the results could reflect residual confounding by severity of illness, these data provide no evidence for a survival benefit afforded by CRRT. Larger, prospective, randomized clinical trials to compare CRRT and IHD in severe AKI are needed.

[1]  D. Mendelssohn,et al.  Current Canadian Approaches to Dialysis for Acute Renal Failure in the ICU , 2002, American Journal of Nephrology.

[2]  C. Sprung,et al.  Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study , 2005, Critical care.

[3]  L A Moyé,et al.  The cardiac arrhythmia suppression trial. Casting suppression in a different light. , 1995, Circulation.

[4]  A. Davenport,et al.  Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. , 1993, Kidney international. Supplement.

[5]  M. Griffin,et al.  Continuous versus intermittent renal replacement therapy: a meta-analysis , 2001, Intensive Care Medicine.

[6]  Jonathan Himmelfarb,et al.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.

[7]  C. Guérin,et al.  Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey , 2002, Intensive Care Medicine.

[8]  R. Swartz,et al.  Predicting the Outcome of Renal Replacement Therapy in Severe Acute Renal Failure , 2002, ASAIO journal (1992).

[9]  A. Bodenham,et al.  The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom , 2003, Anaesthesia.

[10]  E. Paganini,et al.  A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  R. Bellomo,et al.  Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia , 2001, Critical care medicine.

[12]  L. Goldman,et al.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, JAMA.

[13]  William A. Knaus,et al.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, Journal of the American Medical Association (JAMA).

[14]  Vic Hasselblad,et al.  Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. , 2005, JAMA.

[15]  D. DeMets,et al.  A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure , 1998 .

[16]  T. Ikizler,et al.  Reasons for non-enrollment in a cohort study of ARF: the Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials network. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Bellomo,et al.  Answers from the first international course on critical care nephrology questionnaire. , 2001, Contributions to nephrology.

[18]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .

[19]  W. Yang,et al.  Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit , 2004, Scandinavian journal of urology and nephrology.

[20]  S. Chevret,et al.  A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure , 1996, Intensive Care Medicine.

[21]  W. Clark,et al.  A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. , 1994, Journal of the American Society of Nephrology : JASN.

[22]  R. Parker,et al.  A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. , 1998, Journal of the American Society of Nephrology : JASN.

[23]  R. Kaplan,et al.  Nephrology consultation in acute renal failure: does timing matter? , 2002, The American journal of medicine.

[24]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[25]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[26]  A. Davenport,et al.  Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. , 1991, Contributions to nephrology.

[27]  D. Shure Pulmonary-artery catheters--peace at last? , 2006, The New England journal of medicine.

[28]  T. Ikizler,et al.  Mortality after acute renal failure: models for prognostic stratification and risk adjustment. , 2006, Kidney international.

[29]  J. Tijssen,et al.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial , 2002, Critical care medicine.

[30]  J. Steingrub,et al.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. , 2006 .

[31]  G. Chertow,et al.  Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. , 1996, The American journal of medicine.

[32]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[33]  R. Bellomo,et al.  Phosphatemic Control during Acute Renal Failure: Intermittent Hemodialysis versus Continuous Hemodiafiltration , 2001, The International journal of artificial organs.

[34]  J. Takala,et al.  Comparison of continuous and intermittent renal replacement therapy for acute renal failure. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  G. Chertow,et al.  Diuretics, mortality, and nonrecovery of renal function in acute renal failure. , 2002, JAMA.

[36]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[37]  R. Kaplan,et al.  A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. , 2001, Kidney international.

[38]  G. Bernard,et al.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. , 2006, The New England journal of medicine.

[39]  T. Golper,et al.  Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. , 2001, Kidney international.

[40]  R. Swartz,et al.  Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure. , 2005, Clinical nephrology.

[41]  J. Vincent,et al.  Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[43]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[44]  D. Matthaei,et al.  Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics , 1977, Klinische Wochenschrift.

[45]  R. Swartz,et al.  Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  D. Feller-Kopman,et al.  Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  R. Schmieder,et al.  Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  D.,et al.  Regression Models and Life-Tables , 2022 .

[49]  D. DeMets,et al.  A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. , 1999, The New England journal of medicine.

[50]  R. Mehta,et al.  Current Status of Renal Replacement Therapy for Acute Renal Failure , 1999, American Journal of Nephrology.